News

4th Invitation to manufacturers and suppliers of medicinal products for treatment of hepatitis B and C to submit an expression of interest for product evaluation (EOI)

The following products were added:

  • Sofosbuvir/Velpatasvir tablet 400mg/100mg
  • Velpatasvir tablet 100mg

 

The following product was removed:

  • Simeprevir capsule 150mg